<code id='3054518A53'></code><style id='3054518A53'></style>
    • <acronym id='3054518A53'></acronym>
      <center id='3054518A53'><center id='3054518A53'><tfoot id='3054518A53'></tfoot></center><abbr id='3054518A53'><dir id='3054518A53'><tfoot id='3054518A53'></tfoot><noframes id='3054518A53'>

    • <optgroup id='3054518A53'><strike id='3054518A53'><sup id='3054518A53'></sup></strike><code id='3054518A53'></code></optgroup>
        1. <b id='3054518A53'><label id='3054518A53'><select id='3054518A53'><dt id='3054518A53'><span id='3054518A53'></span></dt></select></label></b><u id='3054518A53'></u>
          <i id='3054518A53'><strike id='3054518A53'><tt id='3054518A53'><pre id='3054518A53'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:66893
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

          DarronCummings/APLONDON—AU.K.governmentagencyonTuesdaysaidthatitwon’trecommendEliLilly’sMounjaro—par

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Novo pauses ads for weight loss drug Wegovy amid demand

          NovoNordisk'sheadquarters,outsideCopenhagen,Denmark.LISELOTTESABROE/Scanpix/AFPviaGettyImagesNovoNor